MedPath

A systematic review of the suppressive effect of salacinol on postprandial sugar absorption.

Not Applicable
Conditions
Adults whose fasting blood sugar level is within normal to edge range (excluding those under 18, pregnant women, and lactating women, who were not suffering from any diseases).
Registration Number
JPRN-UMIN000053177
Lead Sponsor
FUJIFILM Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Studies which do not meet the key inclusion criteria will be excluded. Intervention studies without a placebo intake group are excluded.

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Suppressive effect on postprandial sugar absorption (Postprandial blood sugar value, blood sugar area under the curve (AUC) and blood insulin area under the curve (AUC))
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath